Drug Type Induced pluripotent stem cells (iPSC) |
Synonyms iPsC Vasculogenic Cell |
Target- |
Mechanism- |
Inactive Indication- |
Originator Organization Vascugen, Inc.Startup |
Active Organization Vascugen, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetic Retinopathy | Preclinical | US | Vascugen, Inc.Startup | 02 Mar 2022 |
Perioperative ischaemia | Preclinical | US | Vascugen, Inc.Startup | 02 Mar 2022 |
Peripheral Arterial Disease | Preclinical | US | Vascugen, Inc.Startup | 02 Mar 2022 |